| Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators |
2022-9-28 |
2022-10-27 |
|
| Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase … |
2022-4-28 |
2022-7-01 |
|
| Inhibiting ubiquitin-specific protease 1 (usp1) |
2022-4-06 |
2022-10-13 |
|
| Methods using hdac11 inhibitors |
2022-4-01 |
2022-7-28 |
|
| Activating pyruvate kinase r |
2022-3-18 |
2022-9-29 |
|
| 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
2022-3-10 |
2022-6-30 |
|
| Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors |
2022-2-10 |
2022-6-02 |
|
| Inhibiting creb binding protein (cbp) |
2022-2-10 |
2022-5-26 |
|
| Inhibiting fatty acid synthase (fasn) |
2022-2-10 |
2022-10-06 |
|
| Inhibiting ubiquitin specific peptidase 30 |
2021-12-21 |
2022-6-16 |
|
| Purinones as ubiquitin-specific protease 1 inhibitors |
2021-10-27 |
2021-12-09 |
|
| Inhibiting cyclic amp-responsive element-binding protein (creb) binding protein … |
2021-9-23 |
2022-3-24 |
|
| Bromodomain inhibitors for androgen receptor-driven cancers |
2021-9-23 |
2022-3-24 |
|
| Activating pyruvate kinase r |
2021-9-17 |
2022-3-24 |
|
| Activating pyruvate kinase r |
2021-6-18 |
2021-10-07 |
|
| INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1) |
2021-4-28 |
2021-8-12 |
|
| Inhibition of ubiquitin-specific protease 30 (usp30) |
2021-4-21 |
2021-4-30 |
|
| Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 … |
2021-4-14 |
2022-2-03 |
|
| Activating pyruvate kinase r and mutants thereof |
2021-4-06 |
2021-7-22 |
|
| Tetrahydroquinoline compositions as bet bromodomain inhibitors |
2021-3-16 |
2021-5-14 |
|
| Inhibiting ubiquitin specific peptidase 9x |
2021-3-14 |
2021-4-29 |
|
| Novel compounds and compositions for inhibition of fasn |
2021-2-26 |
2021-7-15 |
|
| Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino) … |
2021-2-24 |
2021-6-17 |
|
| Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors |
2021-1-28 |
2021-9-23 |
|
| Salts of (s)-(5-cyclobutoxy-2-methyl-6-(1-(piperidin-4-yl)-1h-pyrazol-4-yl)-3,4 … |
2020-12-22 |
2021-3-01 |
|
| Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors |
2020-12-17 |
2021-7-08 |
|
| Treating patients harboring an isocitrate dehydrogenase 1 (idh-1) mutation |
2020-12-04 |
2021-3-25 |
|
| Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 … |
2020-11-12 |
2021-5-06 |
|
| [6,6] fused bicyclic hdac8 inhibitors |
2020-10-08 |
2021-5-13 |
|
| Activating pyruvate kinase r |
2020-9-18 |
2022-12-01 |
|
| Pyruvate Kinase R (PKR) Activating Composition |
2020-9-18 |
2022-5-23 |
|
| Pyruvate kinase r (pkr) activating compositions |
2020-9-18 |
2021-3-25 |
|
| Inhibiting ubiquitin specific peptidase 9x |
2020-9-18 |
2021-3-25 |
|
| Piperidine derivatives and compositions for the inhibition of nicotinamide … |
2020-9-16 |
2021-8-12 |
|
| Novel compounds and compositions for the inhibition of nampt |
2020-9-11 |
2021-8-12 |
|
| Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) … |
2020-8-28 |
2022-3-08 |
2022-3-08 |
| Amido spirocyclic amide and sulfonamide derivatives |
2020-7-31 |
2022-11-01 |
2022-11-01 |
| Treating cancer with a bromodomain and extra-terminal (bet) family inhibitor |
2020-6-30 |
2021-1-07 |
|
| INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1) |
2020-6-04 |
2020-9-24 |
|
| INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1) |
2020-5-15 |
2020-11-19 |
|
| Benzopiperazine compositions as BET bromodomain inhibitors |
2020-5-12 |
2021-8-10 |
2021-8-10 |
| Compounds and compositions for the inhibition of NAMPT |
2020-3-20 |
2022-3-22 |
2022-3-22 |
| Inhibiting cyclic amp-responsive element-binding protein (creb) |
2020-3-13 |
2022-1-19 |
|
| Compositions and methods for treating androgen receptor positive forms of … |
2020-3-13 |
2021-12-10 |
|
| Inhibiting cyclic amp-responsive element-binding protein (creb) |
2020-3-13 |
2022-1-19 |
|
| Composition for inhibiting ubiquitin-specific protease 1 |
2019-12-27 |
2021-10-01 |
|
| Inhibiting ubiquitin specific peptidase 9x |
2019-12-26 |
2022-2-10 |
|
| 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
2019-12-18 |
2020-4-23 |
|
| Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase … |
2019-12-12 |
2020-4-16 |
|
| Inhibiting mutant IDH-1 |
2019-11-25 |
2022-7-05 |
2022-7-05 |
| Alpha-cinnamide compounds and compositions as hdac8 inhibitors |
2019-11-20 |
2020-10-22 |
|
| Treating non-alcoholic steatohepatitis (nash) |
2019-10-29 |
2020-5-07 |
|
| Inhibiting fatty acid synthase (fasn) |
2019-10-10 |
2020-5-14 |
|
| Inhibiting ubiquitin specific peptidase 9x |
2019-9-19 |
2021-11-11 |
|
| Methods of using fasn inhibitors |
2019-8-20 |
2019-12-12 |
|
| Inhibiting deubiquitinase usp25 and usp28 |
2019-8-08 |
2020-2-13 |
|
| Carboxamides as ubiquitin-specific protease inhibitors |
2019-8-08 |
2021-5-28 |
|
| Quinolinone five-membered heterocyclic compounds as mutant-isocitrate … |
2019-7-22 |
2020-10-20 |
2020-10-20 |
| Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors |
2019-7-19 |
2021-3-02 |
2021-3-02 |
| Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as … |
2019-7-18 |
2021-2-23 |
2021-2-23 |
| Inhibitors of creb binding protein (cbp) |
2019-7-01 |
2022-1-31 |
|
| Inhibitors of creb binding protein (cbp) |
2019-7-01 |
2021-9-01 |
2021-9-01 |
| Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors |
2019-5-16 |
2021-7-01 |
|
| Isoindolines as hdac inhibitors |
2019-4-18 |
2019-10-24 |
|
| COMPOSITIONS OF TETRAHYDROQUINOLINE AS INHIBITORS OF BROMINE AND EXTRA TERMINAL … |
2019-4-11 |
2020-9-09 |
|
| Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase … |
2019-3-01 |
2020-2-04 |
2020-2-04 |
| Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors |
2018-12-28 |
2019-7-11 |
|
| Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors |
2018-12-28 |
2019-5-09 |
|
| Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase … |
2018-12-21 |
2019-2-22 |
|
| Treatment of glioblastoma with fasn inhibitors |
2018-10-25 |
2021-8-19 |
|
| COMPOSITIONS OF TETRAHYDRO-IMIDAZO QUINOLINE AS INHIBITORS OF CBP / p300 |
2018-9-14 |
2019-12-18 |
|
| Carboxamides as ubiquitin-specific protease inhibitors |
2018-8-09 |
2022-7-14 |
2022-7-14 |
| METHODS THAT USE HDAC11 INHIBITORS |
2017-10-20 |
2019-1-30 |
|
| Alpha-cinnamide compounds and compositions as hdac8 inhibitors |
2017-9-13 |
2018-5-18 |
|
| Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors |
2017-2-13 |
2017-8-17 |
|
| Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors |
2017-2-13 |
2020-1-16 |
|
| Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
2016-8-22 |
2016-12-08 |
|